BeiGene to Present Final PFS Results from ALPINE Trial Demonstrating Superior PFS for BRUKINSA® Versus IMBRUVICA® in Late-Breaking Oral Session at ASH 2022 - BeiGene Australia

Australia
- Australia
- Canada EN|FR
- China
- Germany
- Global
- Spain
- US

https://ir.beigene.com/news-details/?id=3eaa7080-547b-4792-a670-a496e02046f4

You will be redirected to

Click the link above to continue or CANCEL